MoBE – Workshop on the Societal and Ethical Implications of Microbiome Engineering in Built Environments

February 7, 2024 | Patti Mulligan

This workshop is hosted by the GES Center at NC State and funded by the NSF Precision Microbiome Engineering (PreMiEr) research grant. Wednesday, May 15: Speakers to discuss the State of MoBE Science and Engineering; Social Equity; Bioethics; Risk Governance; Public Perception and Community Engagement; and Integration of SEI with Science and Engineering of the Microbiome [with public livestream] | Thursday, May 16: Presentation of case studies and deliberative discussions...

Continue reading "MoBE – Workshop on the Societal and Ethical Implications of Microbiome Engineering in Built Environments"

Karen Maschke – Nonhuman Animals Containing Human Cells: Ethics and Oversight | GES Colloquium, Spring 2023

January 5, 2023 | Patti Mulligan

This presentation focuses on ethical and oversight issues as they relate to the insertion of human cells into nonhuman animals, e.g., “chimeric research.” ...

Continue reading "Karen Maschke – Nonhuman Animals Containing Human Cells: Ethics and Oversight | GES Colloquium, Spring 2023"

GES Colloquium | Lisa M. Rasmussen – What WWII Scabies Experiments Teach Us About Unregulated Research

January 2, 2019 | Patti Mulligan

GES Colloquium, 4/23/18 - Lisa Rasmussen | Of Mites and Men: What WWII Scabies Experiments Teach Us About Unregulated Research - The number of British soldiers suffering from scabies during WWII significantly affected the war effort. Consequently, the British military funded researcy to study the transmission and treatment of scabies. This colloquium looks at how the researcher interpreted ethical obligations to human subjects prior to modern codes and regulations, and what that can teach us about the ethics of new, unregulated forms of research. ...

Continue reading "GES Colloquium | Lisa M. Rasmussen – What WWII Scabies Experiments Teach Us About Unregulated Research"

Gould quoted in C&EN: Building bioethics into the future of life sciences innovation

August 27, 2018 | Patti Mulligan

Scientists who refuse to engage with ethicists and the public will find themselves at a disadvantage. “Just because you are a scientist and have invented something doesn’t mean you have authority over it,” says Fred Gould, an entomologist and co-director of the Genetic Engineering & Society Center at North Carolina State University. He points to the National Academies report’s advocacy of participatory decision-making. Resistance from the science community based on ethicists and the public not fully understanding the science wears thin, he says. “You are a pretty poor scientist if you can’t explain what these things are about to an ethicist,” he says....

Continue reading "Gould quoted in C&EN: Building bioethics into the future of life sciences innovation"

Justin Biddle – “Antiscience Zealotry?” Values, Epistemic Risk, and the GMO Debate

August 21, 2018 | Patti Mulligan

Justin B. Biddle is an Associate Professor in the School of Public Policy at the Georgia Institute of Technology. His research interests are interdisciplinary in nature, drawing on fields such as philosophy of science, technology, and medicine; bioethics; food studies; ethics of emerging technologies, and science and technology policy. Conceptually, his research explores the relationships between three sets of issues: (1) the role of values in science, technology, and medicine; (2) the epistemic implications of the social organization of research, and (3) ethics and policy. He has explored these relationships primarily in the areas of biomedical research and agricultural biotechnology. ...

Continue reading "Justin Biddle – “Antiscience Zealotry?” Values, Epistemic Risk, and the GMO Debate"

GES Colloquium WordCloud

Gene Drives and Responsible Innovation

December 8, 2017 | Patti Mulligan

It is not often that a new technology is at once hailed as a potential solution to pandemic disease, wildlife conservation and hunger, while also being feared as a potential military and environmental “bioweapon.” Gene drives,...

Continue reading "Gene Drives and Responsible Innovation"

Jason Delborne

Jason Delborne appointed to National Academies Forest Biotech Study Committee

November 30, 2017 | Patti Mulligan

Dr. Jason Delborne has been appointed to the National Academies of Sciences provisional committee on The Potential for Biotechnology to Address Forest Health, or Forest Biotech Study. The study will be looking at the potential uses of biotechnology to mitigate threats to forest tree health, identify ecological, ethical, and societal implications of using this technology in forests, and develop an agenda to address knowledge gaps in its application. ...

Continue reading "Jason Delborne appointed to National Academies Forest Biotech Study Committee"

Workshop: Ethics and Responsible Innovation in STEM

November 17, 2017 | Patti Mulligan

...

Continue reading "Workshop: Ethics and Responsible Innovation in STEM"

Science Cafe

Godwin and Delborne discuss CRISPR and ethics at NC Museum of Science

October 2, 2017 | Patti Mulligan

GES faculty John Godwin and Jason Delborne were at the NC Museum of History on 9.28.17 discussing genetic biocontrol of pest populations, such as CRISPR gene drives to eliminate invasive rodents from islands to protect endangered seabirds. See PowerPoint presentation & livestream video (including slides)....

Continue reading "Godwin and Delborne discuss CRISPR and ethics at NC Museum of Science"

NAS-CEES-Proceedings-OvercomingChallengesEthicsEngineers

Overcoming Challenges to Infusing Ethics into the Development of Engineers: Proceedings of a Workshop (2017)

July 7, 2017 | Patti Mulligan

While all technologies have societal and ethical implications, emerging technologies (e.g. artificial intelligence and genetic engineering) often pose unique ethical challenges. As advances are made in the fields of engineering, it is vital that issues...

Continue reading "Overcoming Challenges to Infusing Ethics into the Development of Engineers: Proceedings of a Workshop (2017)"